Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
JAMA Network Open
|
December 15, 2022
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
Marcela Carausu, Matthieu Carton, Véronique Diéras, et al.
British Journal of Cancer
|
October 7, 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations
William Jacot, Amélie Lusque, Cécile Vicier, et al.
Radiology
|
September 3, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.
NPJ Breast Cancer
|
February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer
Clara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
Radiology
|
July 1, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Derek Lollivier, Justine Spriet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial
François-Clément Bidard, Nicolas Kiavue, William Jacot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Luc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
Oncogene
|
March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
Angiogenesis
|
November 28, 2019
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
Antoine Vasseur, Luc Cabel, Olivier Tredan, et al.
Oncogene
|
November 4, 2022
Microsatellite instability detection in breast cancer using drop-off droplet digital PCR
Khadidja Zeyneb Klouch, Marc-Henri Stern, Olfa Trabelsi-Grati, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
JAMA Network Open
|
December 15, 2022
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
Marcela Carausu, Matthieu Carton, Véronique Diéras, et al.
British Journal of Cancer
|
October 7, 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations
William Jacot, Amélie Lusque, Cécile Vicier, et al.
Radiology
|
September 3, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.
NPJ Breast Cancer
|
February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer
Clara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
Radiology
|
July 1, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Derek Lollivier, Justine Spriet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial
François-Clément Bidard, Nicolas Kiavue, William Jacot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Luc Cabel, Emmanuelle Jeannot, Ivan Bieche, et al.
Oncogene
|
March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
Angiogenesis
|
November 28, 2019
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
Antoine Vasseur, Luc Cabel, Olivier Tredan, et al.
Oncogene
|
November 4, 2022
Microsatellite instability detection in breast cancer using drop-off droplet digital PCR
Khadidja Zeyneb Klouch, Marc-Henri Stern, Olfa Trabelsi-Grati, et al.
Page
of 8